Top News

Kite Pharma Names Regulatory VP




Los Angeles-based Kite Pharma announced this morning that it has named a new VP. The biotechnology company--which is developing treatments for cancer--said it has named Rizwana F. Sproule, Ph.D. as Vice President, Regulatory Affairs. Sproule was previously at Amgen, including serving as Executive Director, Therapeutic Area Head for Oncology Global Regulatory Affairs. She also served at SmithKline Beecham Pharmaceuticals.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel